Creat membership Creat membership
Sign in

Forgot password?

  • Forgot password?
    Sign Up
  • Confirm
    Sign In
home > search

Now showing items 1 - 16 of 58

  • EULAR revised recommendations for the management of fibromyalgia

    Kronisch, C.   Dean, L. E.   Atzeni, F.   Haeuser, W.   Fluss, E.   Choy, E.   Kosek, E.   Amris, K.   Branco, J.   Dincer, F.   Leino-Arjas, P.   Longley, K.   McCarthy, G. M.   Makri, S.   Perrot, S.   Sarzi-Puttini, P.   Taylor, A.   Jones, G. T.  

    Objective The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were ' expert opinion'.Methods A multidisciplinary group from 12 countries assessed evidence with a focus on systematic reviews and meta-analyses concerned with pharmacological/nonpharmacological management for fibromyalgia. A review, in May 2015, identified eligible publications and key outcomes assessed were pain, fatigue, sleep and daily functioning. The Grading of Recommendations Assessment, Development and Evaluation system was used for making recommendations.Results 2979 titles were identified: from these 275 full papers were selected for review and 107 reviews (and/or meta-analyses) evaluated as eligible. Based on metaanalyses, the only ' strong for' therapy-based recommendation in the guidelines was exercise. Based on expert opinion, a graduated approach, the following four main stages are suggested underpinned by shared decision-making with patients. Initial management should involve patient education and focus on nonpharmacological therapies. In case of non-response, further therapies (all of which were evaluated as ' weak for' based on meta-analyses) should be tailored to the specific needs of the individual and may involve psychological therapies (for mood disorders and unhelpful coping strategies), pharmacotherapy (for severe pain or sleep disturbance) and/or a multimodal rehabilitation programme (for severe disability).Conclusions These recommendations are underpinned by high-quality reviews and meta-analyses. The size of effect for most treatments is relatively modest. We propose research priorities clarifying who will benefit from specific interventions, their effect in combination and organisation of healthcare systems to optimise outcome.
    Download Collect

    Antivalle, M.   Batticciotto, A.   Rigamonti, F.   Ditto, M. C.   Gerardi, M. C.   Talotta, R.   Mutti, A.   Sarzi-Puttini, P.  

    Download Collect
  • Psoriatic Arthritis Registries

    Sarzi-Puttini, P.   Varisco, V.   Ditto, M. C.   Benucci, M.   Atzeni, F.  

    Download Collect

    Talotta, R.   Berzi, A. M.   Atzeni, F.   Dell'Acqua, D.   Trabattoni, D.   Sarzi-Puttini, P.  

    Download Collect

    Atzeni, F.   Gianturco, L.   Masala, I. F.   Bongiovanni, S.   Boccassini, L.   Sarzi-Puttini, P.   Turiel, M.  

    Download Collect
  • Pain in rheumatic diseases: how relevant is it?

    Sarzi-Puttini, P.   Atzeni, F.   Salaffi, F.  

    Download Collect
  • Fibromyalgia: A Never-Ending Story of Central and Peripheral Pain Mechanisms

    Sarzi-Puttini, P.   Atzeni, F.  

    Download Collect
  • Fibromyalgia syndrome: still a medical dilemma

    Sarzi-Puttini, P.   Atzeni, F.   Perrot, S.  

    Download Collect
  • Cardiac involvement in rheumatoid arthritis

    Turiel, M.   Sitia, S.   Tomasoni, L.   Cicala, S.   Atzeni, F.   Gianturco, L.   Longhi, M.   De Gennaro Colonna, V.   Sarzi-Puttini, P.  

    Download Collect
  • Pharmacological treatment of fibromyalgia

    Cazzola, M.   Sarzi-Puttini, P.   Buskila, D.   Atzeni, F.  

    Download Collect
  • Early rheumatoid arthritis

    Atzeni, F.   Sarzi-Puttini, P.  

    Download Collect
  • Fibromyalgia syndrome: definition and diagnostic aspects

    Cazzola, M.   Sarzi-Puttini, P.   Stisi, S.   Di Franco, M.   Bazzichi, L.   Carignola, R.   Gracely, R.H   Salaffi, F.   Marinangeli, F.   Torta, R.   Giamberardino, M.A.   Buskila, D.   Spath, M.   Biasi, G.   Cassisi, G.   Casale, R.   Altomonte, L.   Arioli, G.   Alciati, A.   Marsico, A.   Ceccherelli, F.   Leardini, G.   Gorla, R.   Atzeni, F.  

    Download Collect
  • The evaluation of the fibromyalgia patients

    Atzeni, F.   Salaffi, F.   Bazzichi, L.   Gracely, R.H.   Carignola, R.   Torta, R.   Gorla, R.   Marsico, A.   Ceccherelli, F.   Cazzola, M.   Buskila, D.   Spath, M.   Di Franco, M.   Biasi, G.   Cassisi, G.   Stisi, S.   Casale, R.   Altomonte, L.   Arioli, G.   Alciati, A.   Leardini, G.   Marinangeli, F.   Giamberardino, M.A.   Sarzi-Puttini, P.  

    Download Collect
  • From endothelial dysfunction to atherosclerosis

    Sitia, S.   Tomasoni, L.   Atzeni, F.   Ambrosio, G.   Cordiano, C.   Catapano, A.   Tramontana, S.   Perticone, F.   Naccarato, P.   Camici, P.   Picano, E.   Cortigiani, L.   Bevilacqua, M.   Milazzo, L.   Cusi, D.   Barlassina, C.   Sarzi-Puttini, P.   Turiel, M.  

    It has recently emerged that endothelial dysfunction is an early step in the development of atherosclerosis and is mainly characterised by a reduction in the bioavailability of nitric oxide. All of the traditional cardiovascular (CV) risk factors (dyslipidemia, arterial hypertension, hyperglycemia and diabetes) are associated with endothelial dysfunction, and oxidised low-density lipoproteins, the renin-angiotensin axis and insulin resistance play important roles in the pathogenesis of impaired endothelial function. The increased expression of adhesion molecules and pro-inflammatory cytokines leads to abnormal endothelium-dependent vasodilation which could be investigated using vasoreactivity tests such as flow-mediated dilation in the brachial artery. Recently, new evidences showed that the immune system plays an important role in the pathogenesis of endothelial dysfunction and atherosclerosis with a particular regard towards autoimmunity. The high prevalence of the atherosclerotic process in systemic autoimmune diseases supports the hypothesis of the immune pathogenesis. Evaluating coronary microvascular dysfunction by means of transthoracic echocardiography with non-invasive coronary flow reserve assessment is particularly interesting as it could detect preclinical impairment of coronary microvascular function. The discovery that the mechanisms responsible for endothelial damage have a genetic basis could improve the approach to CV diseases. This review summarises the most important aspects of the pathogenesis and development of endothelial dysfunction. with particular attention to the role of traditional CV risk factors, the usefulness of vasoreactivity tests, and the future perspectives opened by genetic studies. (C) 2010 Elsevier B.V. All rights reserved.
    Download Collect
  • Editorial: Fibromyalgia: A Never-Ending Story of Central and Peripheral Pain Mechanisms

    Sarzi-Puttini, P.   Atzeni, F.  

    Download Collect

    Antivalle, M.   Battellino, M.   Ditto, M. C.   Varisco, V.   Chevallard, M.   Rigamonti, F.   Batticciotto, A.   Atzeni, F.   Sarzi-Puttini, P.  

    Download Collect
1 2 3 4


If you have any feedback, Please follow the official account to submit feedback.

Turn on your phone and scan

Submit Feedback